Concepedia
Cancer Chemotherapy and Pharmacology · 2002 · 33 citations · 17 references
MedicineCancer BiologyOncologyChemotherapySolid Tumor PharmacotherapyMalignant NeoplasmsMalignant TumorsSolid Tumor OncologyFecal Excretion ModelingFecal Excretion VariabilityTopotecan TherapyTopotecan-based Therapy
17
Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
Joachim von Pawel, Joan H. Schiller, Frances A. Shepherd et al. · Journal of Clinical Oncology · 1999 · 960 citations
Medicine, Oncology, Pharmacology +12
Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.
Yaw Huei Hsiang, Leroy F. Liu · PubMed · 1988 · 844 citations
Medicine, Molecular Biology, Pharmacology +12
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
W ten Bokkel Huinink, Martin Gore, J Carmichael et al. · Journal of Clinical Oncology · 1997 · 683 citations
Medicine, Oncology, Pharmacology +17
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Johan W. Jonker · JNCI Journal of the National Cancer Institute · 2000 · 639 citations · Full text
Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity
Robert Hertzberg, Mary Jo Caranfa, Kenneth G. Holden et al. · Journal of Medicinal Chemistry · 1989 · 414 citations
Medicine, Medicinal Chemistry, Pharmacology +12